The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials
Purpose. Studies have found that vitamin D supplementation may improve blood lipids in patients with polycystic ovary syndrome, but the results are controversial, so this study will further analyze the effect of vitamin D supplementation on blood lipids in patients with polycystic ovary syndrome. Me...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2021/8849688 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832552753908416512 |
|---|---|
| author | Hong Gao YanTao Li WenNan Yan Fei Gao |
| author_facet | Hong Gao YanTao Li WenNan Yan Fei Gao |
| author_sort | Hong Gao |
| collection | DOAJ |
| description | Purpose. Studies have found that vitamin D supplementation may improve blood lipids in patients with polycystic ovary syndrome, but the results are controversial, so this study will further analyze the effect of vitamin D supplementation on blood lipids in patients with polycystic ovary syndrome. Methods. PubMed, Embase, Cochrane Library, CNKI, and Wanfang databases were searched up to May 2020, to identify randomized controlled trials of the effect of vitamin D supplementation on blood lipids in patients with polycystic ovary syndrome. The Cochrane risk of bias tool was applied to assess the risk of bias, and RevMan5.3 software was used for statistical analysis. Results. Ten studies were included in this study, including 543 subjects. The results of the meta-analysis showed that, compared with placebo, vitamin D supplementation can significantly reduce total cholesterol level (WMD = –11.32, 95% CI = [–14.51, –8.41], P<0.00001), low-density lipoprotein cholesterol level (WMD = –4.83, 95% CI = [–7.52, –2.14], P=0.0004), and triglyceride level (WMD = –8.23, 95% CI = [–13.08, –3.38], P=0.0009, but the effect on high-density lipoprotein cholesterol level is not statistically significant (WMD = –0.32, 95%CI = [–1.24, 0.60], P=0.50). Conclusion. Vitamin D supplementation can significantly reduce total cholesterol, low-density lipoprotein cholesterol, and triglycerides in patients with polycystic ovary syndrome. However, it has no significant effect on high-density lipoprotein cholesterol. |
| format | Article |
| id | doaj-art-0ad96d0425a64cfa97a019b22e1ecf61 |
| institution | Kabale University |
| issn | 1687-8337 1687-8345 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-0ad96d0425a64cfa97a019b22e1ecf612025-02-03T05:57:51ZengWileyInternational Journal of Endocrinology1687-83371687-83452021-01-01202110.1155/2021/88496888849688The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled TrialsHong Gao0YanTao Li1WenNan Yan2Fei Gao3Department of Endocrinology, First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, 030000 Taiyuan, Shanxi Province, ChinaDepartment of Obstetrics and Gynecology, First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, 030000 Taiyuan, Shanxi Province, ChinaDepartment of Endocrinology, First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, 030000 Taiyuan, Shanxi Province, ChinaDepartment of Endocrinology, First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, 030000 Taiyuan, Shanxi Province, ChinaPurpose. Studies have found that vitamin D supplementation may improve blood lipids in patients with polycystic ovary syndrome, but the results are controversial, so this study will further analyze the effect of vitamin D supplementation on blood lipids in patients with polycystic ovary syndrome. Methods. PubMed, Embase, Cochrane Library, CNKI, and Wanfang databases were searched up to May 2020, to identify randomized controlled trials of the effect of vitamin D supplementation on blood lipids in patients with polycystic ovary syndrome. The Cochrane risk of bias tool was applied to assess the risk of bias, and RevMan5.3 software was used for statistical analysis. Results. Ten studies were included in this study, including 543 subjects. The results of the meta-analysis showed that, compared with placebo, vitamin D supplementation can significantly reduce total cholesterol level (WMD = –11.32, 95% CI = [–14.51, –8.41], P<0.00001), low-density lipoprotein cholesterol level (WMD = –4.83, 95% CI = [–7.52, –2.14], P=0.0004), and triglyceride level (WMD = –8.23, 95% CI = [–13.08, –3.38], P=0.0009, but the effect on high-density lipoprotein cholesterol level is not statistically significant (WMD = –0.32, 95%CI = [–1.24, 0.60], P=0.50). Conclusion. Vitamin D supplementation can significantly reduce total cholesterol, low-density lipoprotein cholesterol, and triglycerides in patients with polycystic ovary syndrome. However, it has no significant effect on high-density lipoprotein cholesterol.http://dx.doi.org/10.1155/2021/8849688 |
| spellingShingle | Hong Gao YanTao Li WenNan Yan Fei Gao The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials International Journal of Endocrinology |
| title | The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials |
| title_full | The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials |
| title_fullStr | The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials |
| title_full_unstemmed | The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials |
| title_short | The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials |
| title_sort | effect of vitamin d supplementation on blood lipids in patients with polycystic ovary syndrome a meta analysis of randomized controlled trials |
| url | http://dx.doi.org/10.1155/2021/8849688 |
| work_keys_str_mv | AT honggao theeffectofvitamindsupplementationonbloodlipidsinpatientswithpolycysticovarysyndromeametaanalysisofrandomizedcontrolledtrials AT yantaoli theeffectofvitamindsupplementationonbloodlipidsinpatientswithpolycysticovarysyndromeametaanalysisofrandomizedcontrolledtrials AT wennanyan theeffectofvitamindsupplementationonbloodlipidsinpatientswithpolycysticovarysyndromeametaanalysisofrandomizedcontrolledtrials AT feigao theeffectofvitamindsupplementationonbloodlipidsinpatientswithpolycysticovarysyndromeametaanalysisofrandomizedcontrolledtrials AT honggao effectofvitamindsupplementationonbloodlipidsinpatientswithpolycysticovarysyndromeametaanalysisofrandomizedcontrolledtrials AT yantaoli effectofvitamindsupplementationonbloodlipidsinpatientswithpolycysticovarysyndromeametaanalysisofrandomizedcontrolledtrials AT wennanyan effectofvitamindsupplementationonbloodlipidsinpatientswithpolycysticovarysyndromeametaanalysisofrandomizedcontrolledtrials AT feigao effectofvitamindsupplementationonbloodlipidsinpatientswithpolycysticovarysyndromeametaanalysisofrandomizedcontrolledtrials |